CompagOs is proud to announce its victory in Venture Kick’s final stage for 150k CHF, impressing the jury with Bon3OID™s’ potential in personalizing treatments in the bone domain. The funds will be used to advance both business and technology development. Additionally, this milestone significantly expands our network through the Kick Foundation and enhances our prospects for further funding.

You can read the full press release here.